Presence of beta-arrestin in cellular inclusions in metamphetamine-treated PC12 cells

A De Blasi1, L Capobianco, L Iacovelli

  • 1I.N.M. Neuromed, località Camerelle, Pozzilli (IS), Italy.

Insights

Methamphetamine (MA) treatment causes ubiquitin and alpha-synuclein inclusions in PC12 cells. Beta-arrestin is ubiquitinated and found in these inclusions, suggesting its role in their development.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Cellular inclusions containing ubiquitin and alpha-synuclein are hallmarks of neurodegenerative diseases.
  • The role of beta-arrestin in the formation of these inclusions is not well understood.

Purpose of the Study:

  • To investigate the potential involvement of beta-arrestin in the formation of cellular inclusions induced by methamphetamine (MA).
  • To analyze the ubiquitin-proteasome pathway (UPP) in response to MA treatment.

Main Methods:

  • PC12 cells were treated with MA for varying durations.
  • Ubiquitination of beta-arrestin was assessed.
  • Electron microscopy and confocal microscopy were employed to visualize cellular structures.

Main Results:

  • Beta-arrestin was found to be ubiquitinated in MA-treated PC12 cells.
  • Confocal and electron microscopy confirmed the presence of beta-arrestin within Lewy body-like inclusions.
  • A connection between beta-arrestin, ubiquitination, and inclusion body formation was observed.

Conclusions:

  • Beta-arrestin is ubiquitinated and incorporated into cellular inclusions formed by MA treatment.
  • These findings suggest a novel role for beta-arrestin in the ubiquitin-proteasome pathway and the pathogenesis of inclusion bodies.

Related Concept Videos